- $1.13bn
- $2.97bn
- $10.33bn
- 76
- 92
- 55
- 88
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 7.94 | ||
| PEG Ratio (f) | 0.45 | ||
| EPS Growth (f) | 21.35% | ||
| Dividend Yield (f) | 0.02% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.31 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 8.69 | ||
| Price to Sales | 0.11 | ||
| EV to EBITDA | 7.43 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.7% | ||
| Return on Equity | -4.83% | ||
| Operating Margin | 1.11% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 9,210.94 | 8,480.18 | 9,785.32 | 9,955.48 | 10,333.97 | 10,712.96 | 11,133.25 | 1.87% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +93.56 | -79.52 | +69.3 | +23.48 | +20.82 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Owens & Minor, Inc. is a global healthcare solutions company providing essential products and services that support care from the hospital to the home. The Company operates through two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a comprehensive portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products purchased from manufacturers and its own proprietary products. Its service offerings to healthcare providers include supplier management, analytics, inventory management, and clinical supply management. It also offers a variety of programs providing outsourced logistics and marketing solutions to its suppliers as well. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and a provider of integrated home healthcare equipment and related services.
Directors
- Mark Beck NEC (55)
- Edward Pesicka PRE (53)
- Andrew Long CFO (55)
- Christopher Lowery CEX (57)
- Jeffrey Jochims COO (53)
- Shana Neal CHO (55)
- Nicholas Pace EVP (50)
- Mark Zacur EVP (58)
- Michael Lowry SVP (59)
- Jonathan Leon SVP (54)
- Aster Angagaw IND (57)
- Gwendolyn Bingham IND (61)
- Robert Henkel IND (66)
- Stephen Klemash IND (60)
- Mark McGettrick IND (63)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- December 20th, 1993
- Public Since
- March 17th, 1980
- No. of Shareholders
- 2,238
- No. of Employees
- 13,700
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 77,096,148
- Address
- 9120 LOCKWOOD BLVD, MECHANICSVILLE, 23116
- Web
- https://www.owens-minor.com/
- Phone
- +1 8047237000
- Contact
- Nick Teves
- Auditors
- KPMG LLP
Upcoming Events for OMI
Q4 2024 Owens & Minor Inc Earnings Release
Similar to OMI
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
Avanos Medical
New York Stock Exchange
FAQ
What is the Owens & Minor share price?
As of Today at 22:30 UTC, shares in Owens & Minor are trading at $14.68. This share price information is delayed by 15 minutes.
How has the Owens & Minor share price performed this year?
Shares in Owens & Minor last closed at $14.68 and the price had moved by -5.47% over the past 365 days. In terms of relative price strength the Owens & Minor share price has underperformed the S&P500 Index by -29.18% over the past year.
What are the analyst and broker recommendations for Owens & Minor?
The overall consensus recommendation for Owens & Minor is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Owens & Minor dividend yield?
Owens & Minor does not currently pay a dividend.
Does Owens & Minor pay a dividend?
Owens & Minor does not currently pay a dividend.
When does Owens & Minor next pay dividends?
Owens & Minor does not currently pay a dividend.
How do I buy Owens & Minor shares?
To buy shares in Owens & Minor you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Owens & Minor?
As of the previous close price of $14.68, shares in Owens & Minor had a market capitalisation of $1.13bn.
Where are Owens & Minor shares listed?
Here are the trading details for Owens & Minor:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: OMI
What kind of share is Owens & Minor?
Based on an overall assessment of its quality, value and momentum Owens & Minor is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Owens & Minor share price forecast for 2024?
The analyst consensus target price for shares in Owens & Minor is $19.75. That is 34.54% above the last closing price of $14.68.
Analysts covering Owens & Minor currently have a consensus Earnings Per Share (EPS) forecast of $1.60 for the next financial year.
Find out moreWhat is the trend in the Owens & Minor share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Owens & Minor. Over the past six months, its share price has underperformed the S&P500 Index by -50.6%.
As of the last closing price of $14.68, shares in Owens & Minor were trading -23.4% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Owens & Minor PE Ratio?
The Owens & Minor PE ratio based on its reported earnings over the past 12 months is 7.94. The shares last closed at $14.68.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Owens & Minor?
Owens & Minor's management team is headed by:
- Mark Beck - NEC
- Edward Pesicka - PRE
- Andrew Long - CFO
- Christopher Lowery - CEX
- Jeffrey Jochims - COO
- Shana Neal - CHO
- Nicholas Pace - EVP
- Mark Zacur - EVP
- Michael Lowry - SVP
- Jonathan Leon - SVP
- Aster Angagaw - IND
- Gwendolyn Bingham - IND
- Robert Henkel - IND
- Stephen Klemash - IND
- Mark McGettrick - IND